Recent advances in the prevention of CMV infection and disease after hematopoietic stem cell transplantation.
about
High-content flow cytometry and temporal data analysis for defining a cellular signature of graft-versus-host disease.Safety and immunogenicity of a bivalent cytomegalovirus DNA vaccine in healthy adult subjects.Progress toward an elusive goal: current status of cytomegalovirus vaccines.IL-23 plasma level is strongly associated with CMV status and reactivation of CMV in renal transplant recipients.Efficiency and risk factors for CMV transmission in seronegative hematopoietic stem cell recipientsDevelopment and preclinical evaluation of an alphavirus replicon particle vaccine for cytomegalovirus.Clinical Usefulness of Monitoring Cytomegalovirus-Specific Immunity by Quantiferon-CMV in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients.Real-time PCR diagnostics failure caused by nucleotide variability within exon 4 of the human cytomegalovirus major immediate-early gene.Human cytomegalovirus antiviral drug resistance in hematopoietic stem cell transplantation: current state of the art.Prolonged anorexia and elevated plasma cytokine levels following myeloablative allogeneic hematopoietic cell transplant.Detection of Two Drug-Resistance Mutants of the Cytomegalovirus by High-Resolution Melting Analysis.Rapid detection directly from patient serum samples of human cytomegalovirus UL97 mutations conferring ganciclovir resistance.Management of cytomegalovirus infection in haemopoietic stem cell transplantation.Artesunate as a potent antiviral agent in a patient with late drug-resistant cytomegalovirus infection after hematopoietic stem cell transplantation.Successful immunotherapy of HCMV disease using virus-specific T cells expanded from an allogeneic stem cell transplant recipient.Genotyping cytomegalovirus UL97 mutations by high-resolution melting analysis with unlabeled probe.
P2860
Q31113879-817C2B03-9710-41E4-A5DC-55103514178CQ34205476-0D55F653-99C1-4ACA-9826-7F9C3DBA2B54Q34434818-04184311-CB97-49FF-9D3D-5866659A469AQ36156499-D97E7451-7462-4D2A-AA44-3275803FBF52Q36611167-958FB322-B561-481C-A492-8D5A9C9F45B2Q37347128-13153E8C-4A41-4715-8E32-AF500BAB9AEBQ37683007-69A69383-D3B2-4502-912A-BB38A509F43CQ38305695-D8A1047C-DC86-4A9D-91CE-7CA05A796C22Q38779846-0C5FAA00-B76D-4F6E-96CE-0A9B104309BFQ40441867-88C97D60-3991-4D9A-81F9-5B68DD3BCA97Q41742346-3E39D7F7-D3FF-492C-92ED-0EA59E59335EQ41880732-31FA7945-642E-4E30-A05A-4CEAC24511E5Q44714539-C338EC8C-0F85-4011-BB60-8F8942D1308AQ46639393-D72402E6-D953-4699-BA2D-462D5A98D9E7Q53359572-D227E607-749C-47AA-8EC7-37BDB5E63ED7Q54540115-8317DABD-C1EA-4DB9-99F8-D39E23248B90
P2860
Recent advances in the prevention of CMV infection and disease after hematopoietic stem cell transplantation.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Recent advances in the prevent ...... tic stem cell transplantation.
@ast
Recent advances in the prevent ...... tic stem cell transplantation.
@en
type
label
Recent advances in the prevent ...... tic stem cell transplantation.
@ast
Recent advances in the prevent ...... tic stem cell transplantation.
@en
prefLabel
Recent advances in the prevent ...... tic stem cell transplantation.
@ast
Recent advances in the prevent ...... tic stem cell transplantation.
@en
P2860
P1476
Recent advances in the prevent ...... tic stem cell transplantation.
@en
P2093
Bettina Fries
W Garrett Nichols
P2860
P356
10.1111/J.1398-2265.2004.00183.X
P478
P577
2004-06-01T00:00:00Z